Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease

Clinical trial NCT00265148 · COMPLETED

Trial details

NCT number: NCT00265148
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2004-05-18
Primary completion: 2008-07-10
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.